Arcadia Biosciences Cash Flow - Annual (NASDAQ:RKDA)

Add to My Stocks
$0.69 $0.11 (13.53%) RKDA stock closing price Mar 22, 2017 (Closing)

The cash flow statement is one of the reports a publicly traded company like Arcadia Biosciences needs to disclose. Financials statements like the income statement and balance sheet show that the company has Arcadia Biosciences profits and Arcadia Biosciences debt, while the cash flow statement provides details of cash flow movments. Arcadia Biosciences cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents.  Arcadia Biosciences had cash and cash equivalents of $16.57M at the beginning of the year and $23.97M at year end for 2015.   Arcadia Biosciences has a positive cash and cash equivalents change of $7.4M. View details of Arcadia Biosciences cash flows for latest & last ten financial years.

show more
Fiscal year is Jan - Dec. 2015 2014 2013
Arcadia Biosciences Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow0.37M0.35M0.39M
Net Increase (Decrease) in Assets Liabilities-0.05M-1.33M-0.14M
Cash From (used in) Discontinued Operations---
Other Adjustments Net2.52M4.53M3.2M
Arcadia Biosciences Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.14M-0.14M-0.1M
Acquisition Disposition of Subsidiaires--1.45M-0.5M
Increase (Decrease) in Investments-46.21M--
Other Cash Inflow (Outflow) from Investment Activities---
Arcadia Biosciences Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares68.58M32.86M0.01M
Issuance (Repayment) of Debt Securities10.2M-1.15M7.83M
Increase (Decrease) in Bank & Other Borrowings---
Payment of Dividends & Other Cash Distributions---
Other Cash from (used by) Financing Activities
Arcadia Biosciences Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---
Arcadia Biosciences Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year16.57M2.83M5.35M
Cash & Equivalents at Year End23.97M16.57M2.83M
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Cash flow for another ticker

While Arcadia Biosciences stock price history provides the price history of a stock, Arcadia Biosciences stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:
  • Arcadia Biosciences has cash of $23.97M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Arcadia Biosciences stock price.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Arcadia Biosciences lost $0.32M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash from investing stood at a negative value of $-46.36M for RKDA stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $68.87M for Arcadia Biosciences.

Key Financial Ratios For Arcadia Biosciences Cash Flow

FCF margin